Andrew Biggin

2.5k total citations
43 papers, 895 citations indexed

About

Andrew Biggin is a scholar working on Genetics, Molecular Biology and Nephrology. According to data from OpenAlex, Andrew Biggin has authored 43 papers receiving a total of 895 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 10 papers in Molecular Biology and 9 papers in Nephrology. Recurrent topics in Andrew Biggin's work include Connective tissue disorders research (15 papers), Parathyroid Disorders and Treatments (9 papers) and Bone health and treatments (8 papers). Andrew Biggin is often cited by papers focused on Connective tissue disorders research (15 papers), Parathyroid Disorders and Treatments (9 papers) and Bone health and treatments (8 papers). Andrew Biggin collaborates with scholars based in Australia, United Kingdom and United States. Andrew Biggin's co-authors include Craig F. Munns, Bruce Bennetts, Aaron Schindeler, Julie Briody, Andrew P. Roberts, Maggie Brett, Lesley C. Adès, Katherine Holman, Erik A. Imel and Christine Rodda and has published in prestigious journals such as SHILAP Revista de lepidopterología, Earth and Planetary Science Letters and The American Journal of Human Genetics.

In The Last Decade

Andrew Biggin

38 papers receiving 882 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew Biggin Australia	18	350	301	155	154	130	43	895
Tohru Takeuchi Japan	23	105 0.3×	227 0.8×	667 4.3×	182 1.2×	468 3.6×	128	1.8k
R. M. Hutchinson United Kingdom	15	46 0.1×	240 0.8×	73 0.5×	158 1.0×	34 0.3×	33	1.1k
David Stenger Germany	13	492 1.4×	105 0.3×	16 0.1×	34 0.2×	77 0.6×	24	849
Helen Turner United Kingdom	30	198 0.6×	697 2.3×	49 0.3×	311 2.0×	511 3.9×	84	3.1k
Thomas J. Barrett United States	14	94 0.3×	208 0.7×	41 0.3×	34 0.2×	26 0.2×	33	622
Fumio Yamasaki Japan	21	32 0.1×	224 0.7×	110 0.7×	255 1.7×	135 1.0×	66	1.1k
John S. Vorhies United States	15	87 0.2×	446 1.5×	11 0.1×	54 0.4×	56 0.4×	47	1.1k
Yuanyuan Hu China	13	48 0.1×	180 0.6×	25 0.2×	132 0.9×	35 0.3×	45	557
Giovanni Quarta Italy	21	18 0.1×	185 0.6×	68 0.4×	232 1.5×	91 0.7×	79	1.6k
Victor C. Kok Taiwan	16	36 0.1×	456 1.5×	49 0.3×	211 1.4×	117 0.9×	54	1.1k

Countries citing papers authored by Andrew Biggin

Since Specialization

Citations

This map shows the geographic impact of Andrew Biggin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Biggin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Biggin more than expected).

Fields of papers citing papers by Andrew Biggin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Biggin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Biggin. The network helps show where Andrew Biggin may publish in the future.

Co-authorship network of co-authors of Andrew Biggin

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Biggin. A scholar is included among the top collaborators of Andrew Biggin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Biggin. Andrew Biggin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Black, Sarah, F. Ellis McKenzie, Craig Jefferies, et al.. (2025). Six cases of ENPP1 pathogenic variants causing autosomal recessive hypophosphatemic rickets type 2 and generalized arterial calcification of infancy. JBMR Plus. 9(Supplement_5). v47–v57.

Rodda, Christine, et al.. (2025). What is it like living with X-linked hypophosphatemia?: results from an Australian consumer survey. JBMR Plus. 9(Supplement_5). v3–v13.

Simm, Peter, et al.. (2025). Hearing impairment in X-linked hypophosphatemia: a review. JBMR Plus. 9(Supplement_5). v14–v29.

Biggin, Andrew, et al.. (2025). X‐Linked Hypophosphataemia and Burosumab: A Systemic Disease With a New Treatment. Journal of Paediatrics and Child Health. 61(5). 685–700.

Munns, Craig F., et al.. (2023). Craniosynostosis in Patients With X‐Linked Hypophosphatemia: A Review. JBMR Plus. 7(5). e10728–e10728. 4 indexed citations

Wheeler, Benjamin J., Craig Jefferies, Anne Morris, et al.. (2023). Prevalence and characteristics of paediatric X-linked hypophosphataemia in Australia and New Zealand: Results from the Australian and the New Zealand Paediatric Surveillance Units survey. Bone. 173. 116791–116791. 11 indexed citations

Boon, Annique van der, Andrew Biggin, Greig A. Paterson, & Janine Kavanagh. (2022). Magnetic to the Core – communicating palaeomagnetism with hands-on activities. SHILAP Revista de lepidopterología. 5(1). 55–66. 1 indexed citations

London, Kevin, et al.. (2022). Denosumab for central giant cell granuloma in an Australian tertiary paediatric centre. Bone. 159. 116395–116395. 18 indexed citations

Cheng, Tegan L., et al.. (2022). Combination treatment with growth hormone and zoledronic acid in a mouse model of Osteogenesis imperfecta. Bone. 159. 116378–116378. 8 indexed citations

10.

Burns, Joshua, Paula Bray, Anita J. Mudge, et al.. (2021). L‐carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1: A Phase 2a clinical trial. American Journal of Medical Genetics Part A. 185(10). 2976–2985. 12 indexed citations

11.

Briody, Julie, Bruce Bennetts, Karen Wong, et al.. (2020). High Bone Mineral Density Osteogenesis Imperfecta in a Family with a Novel Pathogenic Variant in <b><i>COL1A2</i></b>. Hormone Research in Paediatrics. 93(4). 263–271. 2 indexed citations

12.

Sprain, Courtney J., Andrew Biggin, Richard K. Bono, et al.. (2020). Assessing the Robustness of Long-term Field Variations in the Paleomagnetic Record. AGU Fall Meeting Abstracts. 2020. 1 indexed citations

13.

Coorey, Craig P., Andrew Biggin, Julie Briody, et al.. (2018). Diagnosis of Recurrent Fracture in a Pediatric Cohort. Calcified Tissue International. 103(5). 529–539. 9 indexed citations

14.

Biggin, Andrew, Bruce Bennetts, Karen Wong, et al.. (2018). Novel variant in Sp7/Osx associated with recessive osteogenesis imperfecta with bone fragility and hearing impairment. Bone. 110. 66–75. 40 indexed citations

15.

Biggin, Andrew & Craig F. Munns. (2017). Long-Term Bisphosphonate Therapy in Osteogenesis Imperfecta. Current Osteoporosis Reports. 15(5). 412–418. 47 indexed citations

16.

Munns, Craig F., Somayyeh Fahiminiya, Maria Cristina Munteanu, et al.. (2015). Homozygosity for Frameshift Mutations in XYLT2 Result in a Spondylo-Ocular Syndrome with Bone Fragility, Cataracts, and Hearing Defects. The American Journal of Human Genetics. 96(6). 971–978. 57 indexed citations

17.

Biggin, Andrew, et al.. (2013). Evaluation of bone mineral density and morphology using pQCT in children after spinal cord injury. Developmental Neurorehabilitation. 16(6). 391–397. 20 indexed citations

18.

Adès, Lesley C., Kathleen E. Sullivan, Andrew Biggin, et al.. (2006). FBN1, TGFBR1, and the Marfan‐craniosynostosis/mental retardation disorders revisited. American Journal of Medical Genetics Part A. 140A(10). 1047–1058. 69 indexed citations

19.

Biggin, Andrew, R. Michael Henke, Bruce Bennetts, David R. Thorburn, & John Christodoulou. (2004). Mutation screening of the mitochondrial genome using denaturing high-performance liquid chromatography. Molecular Genetics and Metabolism. 84(1). 61–74. 45 indexed citations

20.

Biggin, Andrew, Katherine Holman, Maggie Brett, Bruce Bennetts, & Lesley C. Adès. (2003). Detection of thirty novelFBN1mutations in patients with Marfan syndrome or a related fibrillinopathy. Human Mutation. 23(1). 99–99. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact